Dr. Zaro is a chemical biologist with expertise in mass spectrometry-based proteomics, chemical probe development and drug metabolism. Her laboratory has two main research foci: 1) identifying and interrogating innate immune signaling axes in cancer and infectious disease, 2) exploiting differential drug metabolism in order to develop selective therapeutics. Dr. Zaro is interested in understanding what proteins are critical for how Borrelia burgdorferi evade the innate immune system during infection with the hope of developing novel therapeutics to assist in clearing infection.
Dr. Zaro received her Ph.D. from the University of Southern California prior to post-doctoral studies with Benjamin Cravatt (Scripps Research) and Irving Weissman (Stanford School of Medicine). She is currently an Assistant Professor, Pharmaceutical Chemistry at University of California San Francisco.